Hormone Replacement Therapy: Daily Management
At a Glance
Daily hormone replacement therapy for Addison's disease requires finding the lowest effective dose of hydrocortisone (to replace cortisol) and fludrocortisone (to replace aldosterone). Managing this careful balance prevents long-term side effects like bone loss while controlling daily symptoms.
Managing Addison’s disease is a delicate balancing act. Because your body can no longer produce the hormones it needs to survive, you must replace them with medications that mimic your body’s natural patterns as closely as possible [1]. The goal of Hormone Replacement Therapy (HRT) is to find the lowest effective dose that allows you to feel well while avoiding the long-term side effects of taking too much medication [1][2].
Mimicking the Natural Rhythm: Glucocorticoids
Hydrocortisone is the most common medication used to replace cortisol [1]. In a healthy body, cortisol levels are not steady; they peak in the early morning to help you wake up and slowly drop throughout the day [1].
To mimic this “circadian rhythm,” most patients use split-dosing [1]. This usually involves:
- The Morning Dose: The largest dose, taken immediately upon waking [1].
- The Mid-day Dose: A smaller dose taken around lunch to prevent an afternoon “crash.”
- The Afternoon/Evening Dose: Some patients require a third, very small dose in the late afternoon to carry them through to the next morning [1][3].
Taking your medication in several small doses throughout the day helps keep your energy stable and prevents the “rollercoaster” effect of high and low hormone levels [1].
Managing Salt and Pressure: Mineralocorticoids
Fludrocortisone replaces the hormone aldosterone [1]. Its primary job is to tell your kidneys to hold onto salt and water, which keeps your blood pressure and electrolytes in a healthy range [4]. Extreme heat, heavy sweating, or endurance exercise can increase the body’s demand for salt and may require temporary adjustments to dietary salt intake or hydration [5].
Your doctor will monitor several signs to ensure your dose is correct:
- Clinical Signs: They will check for salt cravings, dizziness when standing (orthostatic hypotension), and swelling in your ankles [6][7].
- Blood Work: The most sensitive marker for your fludrocortisone dose is often plasma renin activity [8][6]. If renin is high, it usually means your body is “starving” for more salt and your dose may need to be increased [8].
The Role of DHEA
The third hormone lost in Addison’s disease is DHEA. While not strictly “essential for life” like cortisol and aldosterone, a lack of DHEA can affect quality of life, particularly for women [9][10].
Current medical evidence regarding DHEA replacement is mixed [11]. It is not considered a standard “required” treatment, but some doctors may suggest a trial period if you continue to experience:
The Danger of “Too Much” (Over-replacement)
It may be tempting to take extra medication to “feel better” or have more energy, but long-term over-replacement carries significant risks [1][2]. Taking more cortisol than your body needs over several years can lead to:
- Bone Loss: An increased risk of osteoporosis (weak bones) and fractures [13][14].
- Metabolic Issues: Weight gain, especially around the stomach, and an increased risk of developing Type 2 diabetes or high blood pressure [1][2].
- Cardiovascular Strain: Extra strain on the heart and blood vessels [1].
A Critical Reassurance: Short-term “stress dosing” during an illness will NOT cause these long-term issues. Preventing a life-threatening adrenal crisis is always the priority. You should never hesitate to double your dose when you are acutely sick out of fear of bone loss or weight gain. These side effects only occur from taking too much medication daily over months and years. Because of these risks, your care team will always strive for the “minimum effective dose” for your daily maintenance, but not for your emergency care [1][15].
Common questions in this guide
Why do I need to take hydrocortisone multiple times a day?
How does my doctor know if my fludrocortisone dose is correct?
Will taking too much hydrocortisone cause side effects?
Should I take DHEA for Addison's disease?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my symptoms and renin levels, is my current dose of fludrocortisone appropriately managing my salt balance?
- 2.Why did you choose my specific hydrocortisone dosing schedule (e.g., twice vs. three times daily)?
- 3.How often should we monitor my bone density (DEXA scan) to ensure my replacement therapy isn't causing bone loss?
- 4.If I continue to experience low libido or persistent low mood, would a trial of DHEA replacement be appropriate for me?
- 5.Are there signs of metabolic syndrome or cardiovascular risk we should be monitoring as we fine-tune my medication levels?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Autoimmune Addison's disease.
Saverino S, Falorni A
Best practice & research. Clinical endocrinology & metabolism 2020; (34(1)):101379 doi:10.1016/j.beem.2020.101379.
PMID: 32063488 - 2
Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency.
Zdrojowy-Wełna A, Halupczok-Żyła J, Słoka N, et al.
Frontiers in endocrinology 2022; (13()):996157 doi:10.3389/fendo.2022.996157.
PMID: 36407318 - 3
Unusual Dosing of Long-Acting Hydrocortisone in a Rapid Hydrocortisone Metabolizer With Addison's Disease: A Case Report.
Sungar NR, Srinivasan B
Cureus 2025; (17(8)):e90553 doi:10.7759/cureus.90553.
PMID: 40978990 - 4
Addison's disease in pregnancy: Case report, management, and review of the literature.
Margulies SL, Corrigan K, Bathgate S, Macri C
Journal of neonatal-perinatal medicine 2020; (13(2)):275-278 doi:10.3233/NPM-190231.
PMID: 31744021 - 5
Severe hyponatraemia with absence of hyperkalaemia in rapidly progressive Addison's disease.
Thompson MD, Kalmar E, Bowden SA
BMJ case reports 2015; (2015()).
PMID: 26021383 - 6
Performance of renin assays in selecting fludrocortisone dose in children with adrenal disorders.
Morris TJ, Whatmore A, Hamilton L, et al.
Endocrine connections 2024; (13(2)).
PMID: 38165389 - 7
Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor.
Viering DHHM, Bech AP, de Baaij JHF, et al.
Pediatric nephrology (Berlin, Germany) 2021; (36(9)):2731-2737 doi:10.1007/s00467-021-05018-7.
PMID: 33768328 - 8
Plasma Renin: A Useful Marker for Mineralocorticoid Adjustment in Patients With Primary Adrenal Insufficiency.
Piazzola C, Dreves B, Albarel F, et al.
Journal of the Endocrine Society 2024; (8(11)):bvae174 doi:10.1210/jendso/bvae174.
PMID: 39416427 - 9
Dehydroepiandrosterone Sulfate in Diagnosing Mild Autonomous Cortisol Secretion and Adrenal Insufficiency.
Saini J, Salama B, Yu K, et al.
Journal of the Endocrine Society 2025; (9(9)):bvaf136 doi:10.1210/jendso/bvaf136.
PMID: 40909019 - 10
Utilizing dehydroepiandrosterone sulfate and its ratio for detecting mild autonomous cortisol excess in patients with adrenal incidentaloma.
Al-Waeli D, Alidrisi H, Mansour A
Journal of medicine and life 2023; (16(10)):1456-1461 doi:10.25122/jml-2023-0092.
PMID: 38313163 - 11
Should Dehydroepiandrosterone Be Administered to Women?
Wierman ME, Kiseljak-Vassiliades K
The Journal of clinical endocrinology and metabolism 2022; (107(6)):1679-1685 doi:10.1210/clinem/dgac130.
PMID: 35254428 - 12
Detecting adrenal insufficiency in patients with immunoglobulin A nephropathy, lupus nephritis, and transplant recipients qualified for glucocorticoid withdrawal.
Pokrzywa A, Ambroziak U, Foroncewicz B, et al.
Polish archives of internal medicine 2019; (129(12)):874-882 doi:10.20452/pamw.15091.
PMID: 31808753 - 13
Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
Camozzi V, Betterle C, Frigo AC, et al.
Endocrine 2018; (59(2)):319-329 doi:10.1007/s12020-017-1380-8.
PMID: 28795340 - 14
Adrenal crisis after first infusion of zoledronic acid: a case report.
Smrecnik M, Kavcic Trsinar Z, Kocjan T
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018; (29(7)):1675-1678 doi:10.1007/s00198-018-4508-7.
PMID: 29594318 - 15
Adrenal Insufficiency in Adults: A Review.
Vaidya A, Findling J, Bancos I
JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.
PMID: 40522647
This page provides educational information about daily hormone replacement therapy for Addison's disease. Always consult your endocrinologist before adjusting your medication doses or schedules.
Get notified when new evidence is published on Chronic primary adrenal insufficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.